FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2398889275> ?p ?o ?g. }

• W2398889275 abstract "Introduction: Mechanisms underlying tumor progression after chemotherapy are not well understood. Therapeutic treatments can favor the clonal selection of cells with unique properties and different fitness for a given microenvironment. Indeed, tumor cells can induce changes in the structure and composition of the microenvironment to support their growth and spread. Our aim is to study if clonal selection induced by target therapies like Trastuzumab and Lapatinib favors the outgrowth of cells with different microenvironmental crosstalk capability, and in particular the role of fibroblast in the selection of these particular clones. Materials and Methods: In order to investigate if clonal selection induced by target therapies like Trastuzumab and Lapatinib favors the outgrowth of cells with different capability of microenvironmental crosstalk, we developed different cell lines resistant to these drugs from the parental SKBR3, BT474 and MDA-MB-453 Her2+ cells lines. We determined their molecular profile and investigated the changes in the expression of selected genes codifying soluble factors known to induce stromal changes, like chemokines, cytokines, matrix remodeling-related enzymes, angiogenic and neurogenic factors. To study the role of fibroblast in the selection of the resistant clones, and the crosstalk between these two populations, we developed fibroblast immortalized lines derived from breast cancer tumors and normal breast tissue, and study the effect of the fibroblasts in resistant induction, as well as the effect of resistant clones in the fibroblast activation. Results and Discussion: We observed that the major changes in the genes investigated were obtained in the Lapatinib resistant cell lines, suggesting that the acquisition of Lapatinib resistance can provide the tumor with a higher capability of stromal interaction. In vivo, the resistant cell lines showed an invasive growth pattern and higher angiogenesis compared to the parental cell lines. We observed a different pattern of fibroblast distribution in the tumors derived from the resistant cell lines, which display a more infiltrative distribution. The resistant tumors were also more fibroblast-enriched suggesting a higher microenvironment crosstalk capacity. In vitro, we found that the supernatant of breast cancer associated fibroblast was able to induce an increase in the resistant phenotype of parental lines, and that the resistant cell lines were able to induce a slightly activation of fibroblasts. Conclusion: These results highlight the importance of microenvironment in supporting tumor progression after chemotherapy. Citation Format: Patricia Fernandez-Nogueira, Mario Mancino, Gemma Fuster, Estel Enreig, Elisabeth Ametller, Paloma Bragado, Vanessa Almendro, Pere Gascon. Acquisition and maintenance of anti-Her2 target therapies resistance in breast cancer: Role of fibrobroblasts. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Breast Cancer Research; Oct 17-20, 2015; Bellevue, WA. Philadelphia (PA): AACR; Mol Cancer Res 2016;14(2_Suppl):Abstract nr B69." @default.
• W2398889275 created "2016-06-24" @default.
• W2398889275 creator A5002454228 @default.
• W2398889275 creator A5006867583 @default.
• W2398889275 creator A5008076576 @default.
• W2398889275 creator A5008889367 @default.
• W2398889275 creator A5019153476 @default.
• W2398889275 creator A5038345474 @default.
• W2398889275 creator A5056168484 @default.
• W2398889275 date "2016-02-01" @default.
• W2398889275 modified "2023-10-16" @default.
• W2398889275 title "Abstract B69: Acquisition and maintenance of anti-Her2 target therapies resistance in breast cancer: Role of fibrobroblasts" @default.
• W2398889275 doi "https://doi.org/10.1158/1557-3125.advbc15-b69" @default.
• W2398889275 hasPublicationYear "2016" @default.
• W2398889275 type Work @default.
• W2398889275 sameAs 2398889275 @default.
• W2398889275 citedByCount "0" @default.
• W2398889275 crossrefType "proceedings-article" @default.
• W2398889275 hasAuthorship W2398889275A5002454228 @default.
• W2398889275 hasAuthorship W2398889275A5006867583 @default.
• W2398889275 hasAuthorship W2398889275A5008076576 @default.
• W2398889275 hasAuthorship W2398889275A5008889367 @default.
• W2398889275 hasAuthorship W2398889275A5019153476 @default.
• W2398889275 hasAuthorship W2398889275A5038345474 @default.
• W2398889275 hasAuthorship W2398889275A5056168484 @default.
• W2398889275 hasConcept C121608353 @default.
• W2398889275 hasConcept C16930146 @default.
• W2398889275 hasConcept C2776107976 @default.
• W2398889275 hasConcept C2777329042 @default.
• W2398889275 hasConcept C2779786085 @default.
• W2398889275 hasConcept C2780381497 @default.
• W2398889275 hasConcept C2909706936 @default.
• W2398889275 hasConcept C3020616263 @default.
• W2398889275 hasConcept C502942594 @default.
• W2398889275 hasConcept C530470458 @default.
• W2398889275 hasConcept C54355233 @default.
• W2398889275 hasConcept C81885089 @default.
• W2398889275 hasConcept C86803240 @default.
• W2398889275 hasConceptScore W2398889275C121608353 @default.
• W2398889275 hasConceptScore W2398889275C16930146 @default.
• W2398889275 hasConceptScore W2398889275C2776107976 @default.
• W2398889275 hasConceptScore W2398889275C2777329042 @default.
• W2398889275 hasConceptScore W2398889275C2779786085 @default.
• W2398889275 hasConceptScore W2398889275C2780381497 @default.
• W2398889275 hasConceptScore W2398889275C2909706936 @default.
• W2398889275 hasConceptScore W2398889275C3020616263 @default.
• W2398889275 hasConceptScore W2398889275C502942594 @default.
• W2398889275 hasConceptScore W2398889275C530470458 @default.
• W2398889275 hasConceptScore W2398889275C54355233 @default.
• W2398889275 hasConceptScore W2398889275C81885089 @default.
• W2398889275 hasConceptScore W2398889275C86803240 @default.
• W2398889275 hasLocation W23988892751 @default.
• W2398889275 hasOpenAccess W2398889275 @default.
• W2398889275 hasPrimaryLocation W23988892751 @default.
• W2398889275 hasRelatedWork W16425881 @default.
• W2398889275 hasRelatedWork W24698872 @default.
• W2398889275 hasRelatedWork W25311131 @default.
• W2398889275 hasRelatedWork W26593026 @default.
• W2398889275 hasRelatedWork W34079255 @default.
• W2398889275 hasRelatedWork W34965712 @default.
• W2398889275 hasRelatedWork W36253725 @default.
• W2398889275 hasRelatedWork W4034371 @default.
• W2398889275 hasRelatedWork W4723398 @default.
• W2398889275 hasRelatedWork W5542912 @default.
• W2398889275 isParatext "false" @default.
• W2398889275 isRetracted "false" @default.
• W2398889275 magId "2398889275" @default.
• W2398889275 workType "article" @default.